You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》摩通予平安好醫生(01833.HK)「增持」評級 目標價63元
阿思達克 09-03 14:38

摩通發表報告予平安好醫生(01833.HK)「增持」評級,目標價63元,認為公司是內地領先的醫療健康服務供應商,而股價自公布中期業績後已升約50%,認為未來12個月股價仍有上行空間,主要因為可與地方政府商討線上醫療服務償付、線上藥房相關法規最快2020年有望放鬆、私家醫生訂閱計劃推出、更多策略合作公布以及財務表現強勁等,該行估計2019-21年公司收入年複合增長可達43%,料到2021年將可達收支平衡。

該行指出國家醫療保障局於8月30日宣布將納入線上醫療服務,對行業而言屬重要里程碑,相信公司在線上諮詢量上具市場領先地位,加上擁有內部醫療團隊及成本優勢,更可受惠政策推動。

而公司於6月份推出了私家醫生服務,相信未來3-5年將成主要的增長引擎,因為首三月計劃剛起動已錄逾3億元人民幣的合約額,相信產品可助客戶與私家醫生建立長期關係。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account